Search Results 1311-1320 of 16984 for Celecoxib
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
About this study. The primary purpose of this study is to evaluate the risk of progression from Monoclonal Gammopathy of Undetermined Significance (MGUS) to ...
About this study. The purpose of this study is to learn about the effects of three study medicines (encorafenib, cetuximab, and pembrolizumab) given ...
The purpose of this study is to assess the 36-month incidence of pelvic/non-vaginal recurrence among patients with surgical stage I intermediate-risk ...
About this study. Investigators will compare magnetic resonance (MR) elastography and/or ultrasound elastography measurements to other forms of noninvasive ...
Your doctor will perform a test before you take this medicine. Zongertinib belongs to the group of medicines called antineoplastics (cancer medicines). It works ...
WCH/WCE diagnosis will be confirmed using ambulatory blood pressure monitoring (ABPM). Participation eligibility. Participant eligibility includes age, gender, ...
About this study. The purpose of this research is to identify an association between bacterial species and strains and active hidradenitis suppurativa (HS) ...
Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.
Below are current clinical trials. 29 studies in Obstetrics and Gynecology (open studies only). Filter this list of studies by location, status and more.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.